Organon (OGN) Asset Writedowns and Impairment (2021)

Organon has reported Asset Writedowns and Impairment for 1 years, with the latest figure at $7.0 million in Q4 2021.

• Asset Writedowns and Impairment for Q4 2021 came in at $7.0 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2023 was $7.0 million (changed N/A YoY), and the FY2025 annual result was $9.0 million, changed N/A from the prior year.
• Asset Writedowns and Impairment was little changed at $7.0 million in Q4 2021.
• Over five years, Asset Writedowns and Impairment peaked at $7.0 million in Q4 2021 and troughed at $7.0 million in Q4 2021.